⚠ You're viewing a report from October 2023. Subscribe to get the latest →

FDA Enforcement — October 2023 Report

Automated analysis of 35 items from public government data sources. Updated daily.

Summary

35
Total items
20
High impact
15
Medium impact
0
Low impact

High-impact items this period

Acrostak Schweiz AG
CGMP violations in medical device manufacturing
Why: Non-compliance with current good manufacturing practice standards  ·  Oct 31  ·  Impact: HIGH
Dexterity Health, LLC DBA Zazzee Naturals
Unapproved new drug marketed without FDA approval
Why: Pharmaceutical product marketed as drug without premarket FDA approval  ·  Oct 30  ·  Impact: HIGH
Neurotris, Inc. dba A1 Engineering
Medical device lacks PMA/510(k), adulterated and misbranded
Why: Distributing medical devices without required premarket approval or clearance  ·  Oct 27  ·  Impact: HIGH
Brenntag Great Lakes, LLC
CGMP violations in finished pharmaceutical manufacturing
Why: Non-compliance with current Good Manufacturing Practice standards  ·  Oct 26  ·  Impact: HIGH
Abbott Laboratories
Dietary supplement adulteration violation
Why: Manufacturing or distribution of adulterated dietary supplement products  ·  Oct 24  ·  Impact: HIGH
Elemental Herbs Inc. d/b/a ALL good
Adulterated finished pharmaceutical products CGMP violations
Why: Failure to maintain CGMP standards in production facility  ·  Oct 20  ·  Impact: HIGH
WAVi Co.
Adulterated medical device in IDE/PMA application
Why: Medical device fails to meet quality standards under investigational or approval process  ·  Oct 20  ·  Impact: HIGH
Samm Solutions, Inc., d.b.a. BTS Research
Good laboratory practice violations in nonclinical studies
Why: Laboratory fails to meet GLP standards for nonclinical safety testing  ·  Oct 20  ·  Impact: HIGH
Maria W. Greenwald, M.D.
Clinical investigator protocol violations in drug trials
Why: Principal investigator fails to comply with clinical investigation regulations  ·  Oct 20  ·  Impact: HIGH
Global Pharma Healthcare Private Limited
Pharmaceutical adulteration and misbranding CGMP violations
Why: Failure to comply with pharmaceutical manufacturing standards  ·  Oct 20  ·  Impact: HIGH

Selected medium-impact items

Trippy Drips LLC
Tobacco product adulterated or misbranded under FPTCA
Why: Non-compliance with Family Smoking Prevention and Tobacco Control Act requirements  ·  Oct 26  ·  Impact: MEDIUM
FF Vapors, LLC
Tobacco product adulterated or misbranded under FPTCA
Why: Non-compliance with Family Smoking Prevention and Tobacco Control Act requirements  ·  Oct 26  ·  Impact: MEDIUM
Cajun Vapes LLC
Tobacco product adulterated or misbranded under FPTCA
Why: Non-compliance with Family Smoking Prevention and Tobacco Control Act requirements  ·  Oct 26  ·  Impact: MEDIUM
ADM Animal Nutrition
Animal food adulteration and CGMP violations
Why: Failure to maintain Current Good Manufacturing Practice standards  ·  Oct 23  ·  Impact: MEDIUM
The Juice Bar
Adulterated or misbranded tobacco products violation
Why: Non-compliance with Family Smoking Prevention and Tobacco Control Act requirements  ·  Oct 20  ·  Impact: MEDIUM

Get this delivered every week

Free tier: 3 items per vertical. Full access with paid subscription.

Subscribe — $29/mo →

Data sourced from public government APIs. AI analysis via Claude Haiku. Full methodology →